A Review of Ethical Considerations in Conducting Clinical Trials ethical considerations in clinical trials
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 11 No. 4 (2021),
17 November 2021
Clinical trials are known as the golden key in medical science researches with human participants. Therefore, they have always been considered interesting topics by researchers and scientists working in this field. On the other hand, due to the “human participants”, they need to be performed very carefully. In this article, we have examined the ethical necessities and considerations in these researches in four stages: Research Design and Question-proposal review , approval - Supervision, implementation and publication of the results We have dealt with them using articles published between 2010 and 2019, and we have identified significantly important and prominent issues or even neglected cases.
During this study, it was found that the Research Design and Question stage were the most discussed and challenged stages and the authors' sensitivity about them has been more than the other three stages. On the other hand, the results publishing stage with the least number of references in articles has been considered less sensitive.
During this study, it was found that the Research Design was the most discussed and challenged stages and the authors' sensitivity about them has been more than the other three stages. On the other hand, the results publishing stage with the least number of references in articles has been considered less sensitive.
- Clinical Trial
- Ethical Considerations
How to Cite
2. Morgan GA, Harmon RJ. Research Questions and Hypotheses. Journal of the American Academy of Child & Adolescent Psychiatry. 2000;39(2):261-3.
3. Bothwell LE, Kesselheim AS. The Real-World Ethics of Adaptive-Design Clinical Trials. The Hastings Center report. 2017;47(6):27-37.
4. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Annals of internal medicine. 2013;158(3):200-7.
5. Okonta PI. Ethics of clinical trials in Nigeria. Niger Med J. 2014;55(3):188-94.
6. Dowrick AS, Bhandari M. Ethical issues in the design of randomized trials: to sham or not to sham. The Journal of bone and joint surgery American volume. 2012;94 Suppl 1:7-10.
7. van der Graaf R, van Delden JJ. Equipoise should be amended, not abandoned. Clin Trials. 2011;8(4):408-16.
8. Friedman LM, Furberg C, DeMets DL, Reboussin DM, Granger CB. What Is the Question? In: Friedman LMea, editor. Fundamentals of clinical trials: Springer; 2010. p. 49-71.
9. Hey SP, Truog RD. The question of clinical equipoise and patients’ best interests. AMA journal of ethics. 2015;17(12):1108-15.
10. Pillamarapu M, Mohan A, Saberwal G. An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India. 2019;20(1):535.
11. Karlberg JPE, Speers MA. Reviewing clinical trials: a guide for the ethics committee: Hong Kong; 2010.
12. Sim J. Outcome-adaptive randomization in clinical trials: issues of participant welfare and autonomy. Theoretical Medicine and Bioethics. 2019;40(2):83-101.
13. Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, et al. Adaptive designs in clinical trials: why use them, and how to run and report them. BMC medicine. 2018;16(1):29-.
14. Rosemann A. Alter-Standardizing Clinical Trials: The Gold Standard in the Crossfire. Science as Culture. 2019;28(2):125-48.
15. Chen SC, Kim SY. A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials. Clin Trials. 2016;13(6):605-11.
16. Mentz RJ, Hernandez AF, Berdan LG, Rorick T, O'Brien EC, Ibarra JC, et al. Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds. Circulation. 2016;133(9):872-80.
17. Kyte D, Duffy H, Fletcher B, Gheorghe A, Mercieca-Bebber R, King M, et al. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols. PloS one. 2014;9(10):e110229.
18. Hedgecoe A. A deviation from standard design? Clinical trials, research ethics committees, and the regulatory co-construction of organizational deviance. Social Studies of Science. 2014;44(1):59-81.
19. Clark T, Berger U, Mansmann U. Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review. BMJ : British Medical Journal. 2013;346:f1135.
20. Sajdak R, Trembath L, Thomas KS. The importance of standard operating procedures in clinical trials. Journal of nuclear medicine technology. 2013;41(3):231-3.
21. Day S, Jonker AH, Lau LPL, Hilgers RD, Irony I, Larsson K, et al. Recommendations for the design of small population clinical trials. Orphanet journal of rare diseases. 2018;13(1):195.
22. Haynes R, Bowman L, Rahimi K, Armitage J. How the NHS research governance procedures could be modified to greatly strengthen clinical research. Clinical medicine (London, England). 2010;10(2):127-9.
23. Jesani A. New Drugs and Clinical Trials Rules, 2019: The market trumps ethics and participant rights. NEW DRUGS AND CLINICAL TRIALS RULES EXAMINED. 2019;4(2).
24. Maeda K, Katashima R, Ishizawa K, Yanagawa H. Japanese Physicians' Views on Drug Post-Marketing Surveillance. Journal of clinical medicine research. 2015;7(12):956-60.
25. Li R, Barnes M, Aldinger C, Bierer B. Global clinical trials: ethics, harmonization and commitments to transparency. Global Health. 2015;4(1):2.
26. Russ H, Busta S, Jost B, Bethke TD. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa). Ger Med Sci. 2015;13:Doc02-Doc.
27. Ilbars H, Bebitoglu BT. How to get ethics committee approval for clinical trials in Turkey? North Clin Istanb. 2018;5(4):379-86.
28. Nardini C. The ethics of clinical trials. Ecancermedicalscience. 2014;8:387-.
29. Desai M. Ethics committee: critical issues and challenges. Indian J Pharmacol. 2012;44(6):663-4.
30. Thatte UM, Marathe PA. Ethics Committees in India: Past, present and future. Perspect Clin Res. 2017;8(1):22-30.
31. Liu Y, Xinying L. The Function of Medical Ethics Professionals in Ethical Review of Clinical Trials Involving Human Subjects. Chinese Medical Ethics. 2016;29(2):285-7.
32. Kadam R, Karandikar S. Ethics committees in India: Facing the challenges! Perspect Clin Res. 2012;3(2):50-6.
33. Trung LQ, Morra ME, Truong ND, Turk T, Elshafie A, Foly A, et al. A systematic review finds underreporting of ethics approval, informed consent, and incentives in clinical trials. Journal of Clinical Epidemiology. 2017;91:80-6.
34. Vollmer SH, Howard G. Statistical power, the Belmont report, and the ethics of clinical trials. Science and engineering ethics. 2010;16(4):675-91.
35. Lie RK, Chan FKL, Grady C, Ng VH, Wendler D. Comparative effectiveness research: what to do when experts disagree about risks. BMC Med Ethics. 2017;18(1):42.
36. Modi N, Vohra J, Preston J, Elliott C, Van't Hoff W, Coad J, et al. Guidance on clinical research involving infants, children and young people: an update for researchers and research ethics committees. 2014;99(10):887-91.
37. Strech D, Sievers S, Märschenz S, Riedel N, Wieschowski S, Meerpohl J, et al. Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables. F1000Research. 2018;7:1863-.
38. Djulbegovic B, Hozo I. When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guilt. BMC medical research methodology. 2012;12:85.
39. Speich B, Schur N, Gryaznov D. Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation. Trials. 2019;14(1):e0210669.
40. Biggs JS, Marchesi A. Rebuilding a Research Ethics Committee. Journal of Research Administration. 2013;44(1):62-74.
41. Tabarrai M, Qaraaty M, Aliasl J. The Challenges of Clinical Researches in Iranian Traditional Medicine (ITM). Iranian journal of medical sciences. 2016;41(3 Suppl):S60.
42. Li E-c, Du P, Ji K-z, Wang Z. Chinese ethics review system and chinese medicine ethical review: Past, present, and future. Chinese Journal of Integrative Medicine. 2011;17(11):867-72.
43. Kaufman KR. Ethical considerations in placebo-controlled randomised clinical trials. BJPsych open. 2015;1(1):e3-e4.
44. Shepherd V. Research involving adults lacking capacity to consent: the impact of research regulation on 'evidence biased' medicine. BMC Med Ethics. 2016;17(1):55.
45. Jadhav M, Bhatt A. Ethics in clinical research in India: A survey of clinical research professionals' perceptions. Perspect Clin Res. 2013;4(1):4-8.
46. Samadi A, Asghari F. Readability of informed consent forms in clinical trials conducted in a skin research center. J Med Ethics Hist Med. 2016;9:7.
47. Benatar JR, Mortimer J, Stretton M, Stewart RA. A booklet on participants' rights to improve consent for clinical research: a randomized trial. PloS one. 2012;7(10):e47023.
48. Viergever RF, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ open. 2015;5(9):e008932.
49. Viergever RF, Ghersi D. The quality of registration of clinical trials. PloS one. 2011;6(2):e14701-e.
50. Thorogood A, Knoppers BM. Can research ethics committees enable clinical trial data sharing? Ethics, Medicine and Public Health. 2017;3(1):56-63.
51. Saenz C, Reveiz L, Tisdale JF. Public titles of clinical trials should have ethics review. J Clin Epidemiol. 2015;68(9):1105-7.
52. Fakhri F, Eybpoosh S, Solaymani Dodaran M. Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Iranian Registry of Clinical Trials (IRCT). Iranian Journal of Epidemiology. 2019;15(1):8-19.
53. Gøtzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials. 2011;12(1):249.
54. Xuemei L, Youping L, Shangqi S, Senlin Y, Williams S. Ethical review reporting of Chinese trials records in WHO primary registries. Journal of Medical Ethics. 2011;37(3):144-8.
55. Denneny C, Bourne S, Kolstoe SE. Registration audit of clinical trials given a favourable opinion by UK research ethics committees. BMJ open. 2019;9(2):e026840.
56. Dyer C. UK clinical trials must be registered to win ethics committee approval. BMJ : British Medical Journal. 2013;347:f5614.
57. Liu X, Li Y, Yin S, Song S. Result publication of Chinese trials in World Health Organization primary registries. PloS one. 2010;5(9):e12676-e.
58. Dziura JD, Post LA, Zhao Q, Fu Z, Peduzzi P. Strategies for dealing with missing data in clinical trials: from design to analysis. The Yale journal of biology and medicine. 2013;86(3):343-58.
59. Gillies K, Elwyn G, Cook J. Making a decision about trial participation: the feasibility of measuring deliberation during the informed consent process for clinical trials. Trials. 2014;15(1):307.
60. Watson SI, Dixon-Woods M, Lilford RJ. Randomised evaluation of government health programmes does present a challenge to standard research ethics frameworks. Journal of Medical Ethics. 2020;46(1):34-5.
61. Stanev R. Quantitative Framework for Retrospective Assessment of Interim Decisions in Clinical Trials. Medical Decision Making. 2016;36(8):999-1010.
62. Roes K. When is enough evidence available?; interim analyses in clinical trials. Nederlands tijdschrift voor geneeskunde. 2013;157(12):A5660-A.
63. Laage T, Loewy JW, Menon S, Miller ER, Pulkstenis E, Kan-Dobrosky N, et al. Ethical Considerations in Adaptive Design Clinical Trials. Therapeutic Innovation & Regulatory Science. 2017;51(2):190-9.
64. Freidlin B, Othus M, Korn EL. Information time scales for interim analyses of randomized clinical trials. Clinical Trials. 2016;13(4):391-9.
65. Goldacre B, Drysdale H, Dale A, Milosevic I, Slade E, Hartley P, et al. COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time. Trials. 2019;20(1):118.
66. Miller JE, Korn D, Ross JS. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012. BMJ open. 2015;5(11):e009758-e.
67. Bashir R, Dunn AG. Systematic review protocol assessing the processes for linking clinical trial registries and their published results. BMJ open. 2016;6(10):e013048-e.
68. Butcher NJ, Monsour A, Mew EJ, Szatmari P, Pierro A, Kelly LE, et al. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT). Trials. 2019;20(1):161.
69. Strech D, Littmann J. The contribution and attitudes of research ethics committees to complete registration and non-selective reporting of clinical trials: A European survey. Research Ethics. 2016;12(3):123-36.
70. Brassington I. The ethics of reporting all the results of clinical trials. British medical bulletin. 2017;121(1):19-29.
71. Marusic A, Wager E, Utrobicic A, Rothstein HR, Sambunjak D. Interventions to prevent misconduct and promote integrity in research and publication. The Cochrane database of systematic reviews. 2016;4:Mr000038.
72. Asghari F, Ghalandarpoorattar SM. Continuing review of ethics in clinical trials: a surveillance study in Iran. J Med Ethics Hist Med. 2013;6:8.
73. Ghasemzadeh N, Nikravan Fard N, Rahimi Rad MH, Mousavipour S, Faramarzi Razini F. A survey on the rate of observance of research ethics in approved proposals at Urmia University of Medical Sciences (2003 - 2008). Medical Ethics and History of Medicine. 2013;6(2):67-85.
74. Kalantar Motamedi MH. Breaching medical ethics in research. Trauma Mon. 2014;19(2):e17112-e.
- Abstract Viewed: 43 times
- PDF Downloaded: 11 times